This week on Contemporary OB/GYN®: Oct. 18 to Oct. 22
Here's what to look for this week on Contemporary OB/GYN®.
This week's topics include:
Diagnosing and treating vaginal discharge
Moderna, Johnson and Johnson COVID-19 boosters recommended by FDA
The advisory panel is also scheduled to discuss Merck antiviral pill late next month.
Changes in menstrual cycle length could signal increased risk of atherosclerosis
Using data from SWAN DHS, investigators determined changes in menstrual cycle length prior to a woman's final menstrual period were associated with changes in carotid intima-media thickness and brachial-ankle pulse wave velocity.
Combined contraceptive pills may reduce risk of diabetes in PCOS
A pair of studies provide insight into the increased risk of dysglycemia among women with PCOS and the potential influence of combined oral contraceptive pills on this risk in a population-based cohort.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
